Art Community

TrialScreen Inc., Bectas Therapeutics Inc. Recognized as Top Innovators as DIA 2026 Charts the Course Ahead

Startups win pitch competition as thousands of life sciences leaders confront regulatory and technological challengesWASHINGTON, June 25, 2026 /PRNewswire/ — TrialScreen Inc. and Bectas Therapeutics Inc. emerged from a field of 100 applicants and 25 startup pitches to win…

Read the full release →

News provided by PR Newswire.

Ethan Parker

Ethan Parker covers stories about community life, personal well-being, local initiatives, lifestyle trends, and the people working to create stronger communities. His writing looks for the human element behind larger developments, focusing on practical ideas and meaningful stories. Ethan brings an approachable perspective to subjects involving everyday life, community participation, creativity, and social connection.

View all posts

Art Community

WuXi Biologics’ 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations

Ethan Parker June 24, 2026

Art Community

RelaxPLX® Gains Health Canada License, and South Korean Sleep Quality Support Claim

Ethan Parker June 24, 2026

Art Community

Marquis Who’s Who Honors Shawn Patrick O’Brien for Expertise in Pharmaceuticals and Biotechnology

Ethan Parker June 25, 2026

Art Community

Warm Autoimmune Hemolytic Anemia Market to Observe Stunning Growth at a 14.4% CAGR During the Forecast Period (2026-2036) Due to the Emergence of Novel Drug Classes Such as FcRn Inhibitors, BTK Inhibitors, BAFF-R, and Others | DelveInsight

Ethan Parker June 30, 2026

TrialScreen Inc., Bectas Therapeutics Inc. Recognized as Top Innovators as DIA 2026 Charts the Course Ahead

Ethan Parker

WuXi Biologics’ 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations

RelaxPLX® Gains Health Canada License, and South Korean Sleep Quality Support Claim

Marquis Who’s Who Honors Shawn Patrick O’Brien for Expertise in Pharmaceuticals and Biotechnology

Warm Autoimmune Hemolytic Anemia Market to Observe Stunning Growth at a 14.4% CAGR During the Forecast Period (2026-2036) Due to the Emergence of Novel Drug Classes Such as FcRn Inhibitors, BTK Inhibitors, BAFF-R, and Others | DelveInsight

Search

Recent Posts

Pages

Categories

Blogs

Chiraag Shah joins Crowell & Moring’s

Armenian Ambassador Highlights New Opportunities for

Zepp Health Corporation Reports Second Quarter

TrialScreen Inc., Bectas Therapeutics Inc. Recognized as Top Innovators as DIA 2026 Charts the Course Ahead

Ethan Parker

You Might Also Like

WuXi Biologics’ 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations

RelaxPLX® Gains Health Canada License, and South Korean Sleep Quality Support Claim

Marquis Who’s Who Honors Shawn Patrick O’Brien for Expertise in Pharmaceuticals and Biotechnology

Warm Autoimmune Hemolytic Anemia Market to Observe Stunning Growth at a 14.4% CAGR During the Forecast Period (2026-2036) Due to the Emergence of Novel Drug Classes Such as FcRn Inhibitors, BTK Inhibitors, BAFF-R, and Others | DelveInsight

Search

Recent Posts

Chiraag Shah joins Crowell & Moring’s

Armenian Ambassador Highlights New Opportunities for

Zepp Health Corporation Reports Second Quarter